β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia

Martijn L T M Müller, Kirk A. Frey, Myria Petrou, Vikas Kotagal, Robert A. Koeppe, Roger L. Albin, Nicolaas I. Bohnen

Research output: Contribution to journalArticle

Abstract

Although motor impairments in Parkinson's disease (PD) are attributed to nigrostriatal dopaminergic denervation, postural instability and gait difficulty (PIGD) features are less responsive to dopaminergic medications. PIGD features are a risk factor also for the development of dementia in PD (PDD). These observations suggest that nondopaminergic mechanisms may contribute to axial motor impairments. The aim was to perform a correlative PET study to examine the relationship between neocortical β-amyloid deposition ([11C]-Pittsburgh Compound B), nigrostriatal dopaminergic denervation ([11C]-dihydrotetrabenazine), and PIGD feature severity in PD patients at risk for dementia. This was a cross-sectional study of 44 PD patients (11 female and 33 male; 69.5 ± 6.6 years of age; 7.0 ± 4.8 years motor disease duration; mean H & Y stage: 2.7 ± 0.5) who underwent PET, motor feature severity assessment using the Movement Disorder Society revised UPDRS, and the Dementia Rating Scale (DRS). Linear regression (R2adj = 0.147; F4,39 = 2.85; P = 0.036) showed that increased PIGD feature severity was associated with increased neocortical [11C]-Pittsburgh Compound B binding (β = 0.346; t39 = 2.13; P = 0.039) while controlling for striatal [11C]-dihydrotetrabenazine binding, age, and DRS total score. Increased neocortical β-amyloid deposition, even at low-range levels, is associated with higher PIGD feature severity in PD patients at risk for dementia. This finding may explain why the PIGD motor phenotype is a risk factor for the development of PDD.

Original languageEnglish (US)
Pages (from-to)296-301
Number of pages6
JournalMovement disorders : official journal of the Movement Disorder Society
Volume28
Issue number3
DOIs
StatePublished - Mar 2013

Fingerprint

Gait
Amyloid
Parkinson Disease
Dementia
Denervation
Corpus Striatum
Linear Models
Cross-Sectional Studies
Phenotype

Keywords

  • β-amyloid
  • Dopamine
  • MDS-UPDRS
  • Parkinson's disease
  • PET

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. / Müller, Martijn L T M; Frey, Kirk A.; Petrou, Myria; Kotagal, Vikas; Koeppe, Robert A.; Albin, Roger L.; Bohnen, Nicolaas I.

In: Movement disorders : official journal of the Movement Disorder Society, Vol. 28, No. 3, 03.2013, p. 296-301.

Research output: Contribution to journalArticle

Müller, Martijn L T M ; Frey, Kirk A. ; Petrou, Myria ; Kotagal, Vikas ; Koeppe, Robert A. ; Albin, Roger L. ; Bohnen, Nicolaas I. / β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. In: Movement disorders : official journal of the Movement Disorder Society. 2013 ; Vol. 28, No. 3. pp. 296-301.
@article{803c93e429614838a3dc4b813a63fd56,
title = "β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia",
abstract = "Although motor impairments in Parkinson's disease (PD) are attributed to nigrostriatal dopaminergic denervation, postural instability and gait difficulty (PIGD) features are less responsive to dopaminergic medications. PIGD features are a risk factor also for the development of dementia in PD (PDD). These observations suggest that nondopaminergic mechanisms may contribute to axial motor impairments. The aim was to perform a correlative PET study to examine the relationship between neocortical β-amyloid deposition ([11C]-Pittsburgh Compound B), nigrostriatal dopaminergic denervation ([11C]-dihydrotetrabenazine), and PIGD feature severity in PD patients at risk for dementia. This was a cross-sectional study of 44 PD patients (11 female and 33 male; 69.5 ± 6.6 years of age; 7.0 ± 4.8 years motor disease duration; mean H & Y stage: 2.7 ± 0.5) who underwent PET, motor feature severity assessment using the Movement Disorder Society revised UPDRS, and the Dementia Rating Scale (DRS). Linear regression (R2adj = 0.147; F4,39 = 2.85; P = 0.036) showed that increased PIGD feature severity was associated with increased neocortical [11C]-Pittsburgh Compound B binding (β = 0.346; t39 = 2.13; P = 0.039) while controlling for striatal [11C]-dihydrotetrabenazine binding, age, and DRS total score. Increased neocortical β-amyloid deposition, even at low-range levels, is associated with higher PIGD feature severity in PD patients at risk for dementia. This finding may explain why the PIGD motor phenotype is a risk factor for the development of PDD.",
keywords = "β-amyloid, Dopamine, MDS-UPDRS, Parkinson's disease, PET",
author = "M{\"u}ller, {Martijn L T M} and Frey, {Kirk A.} and Myria Petrou and Vikas Kotagal and Koeppe, {Robert A.} and Albin, {Roger L.} and Bohnen, {Nicolaas I.}",
year = "2013",
month = "3",
doi = "10.1002/mds.25213",
language = "English (US)",
volume = "28",
pages = "296--301",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia

AU - Müller, Martijn L T M

AU - Frey, Kirk A.

AU - Petrou, Myria

AU - Kotagal, Vikas

AU - Koeppe, Robert A.

AU - Albin, Roger L.

AU - Bohnen, Nicolaas I.

PY - 2013/3

Y1 - 2013/3

N2 - Although motor impairments in Parkinson's disease (PD) are attributed to nigrostriatal dopaminergic denervation, postural instability and gait difficulty (PIGD) features are less responsive to dopaminergic medications. PIGD features are a risk factor also for the development of dementia in PD (PDD). These observations suggest that nondopaminergic mechanisms may contribute to axial motor impairments. The aim was to perform a correlative PET study to examine the relationship between neocortical β-amyloid deposition ([11C]-Pittsburgh Compound B), nigrostriatal dopaminergic denervation ([11C]-dihydrotetrabenazine), and PIGD feature severity in PD patients at risk for dementia. This was a cross-sectional study of 44 PD patients (11 female and 33 male; 69.5 ± 6.6 years of age; 7.0 ± 4.8 years motor disease duration; mean H & Y stage: 2.7 ± 0.5) who underwent PET, motor feature severity assessment using the Movement Disorder Society revised UPDRS, and the Dementia Rating Scale (DRS). Linear regression (R2adj = 0.147; F4,39 = 2.85; P = 0.036) showed that increased PIGD feature severity was associated with increased neocortical [11C]-Pittsburgh Compound B binding (β = 0.346; t39 = 2.13; P = 0.039) while controlling for striatal [11C]-dihydrotetrabenazine binding, age, and DRS total score. Increased neocortical β-amyloid deposition, even at low-range levels, is associated with higher PIGD feature severity in PD patients at risk for dementia. This finding may explain why the PIGD motor phenotype is a risk factor for the development of PDD.

AB - Although motor impairments in Parkinson's disease (PD) are attributed to nigrostriatal dopaminergic denervation, postural instability and gait difficulty (PIGD) features are less responsive to dopaminergic medications. PIGD features are a risk factor also for the development of dementia in PD (PDD). These observations suggest that nondopaminergic mechanisms may contribute to axial motor impairments. The aim was to perform a correlative PET study to examine the relationship between neocortical β-amyloid deposition ([11C]-Pittsburgh Compound B), nigrostriatal dopaminergic denervation ([11C]-dihydrotetrabenazine), and PIGD feature severity in PD patients at risk for dementia. This was a cross-sectional study of 44 PD patients (11 female and 33 male; 69.5 ± 6.6 years of age; 7.0 ± 4.8 years motor disease duration; mean H & Y stage: 2.7 ± 0.5) who underwent PET, motor feature severity assessment using the Movement Disorder Society revised UPDRS, and the Dementia Rating Scale (DRS). Linear regression (R2adj = 0.147; F4,39 = 2.85; P = 0.036) showed that increased PIGD feature severity was associated with increased neocortical [11C]-Pittsburgh Compound B binding (β = 0.346; t39 = 2.13; P = 0.039) while controlling for striatal [11C]-dihydrotetrabenazine binding, age, and DRS total score. Increased neocortical β-amyloid deposition, even at low-range levels, is associated with higher PIGD feature severity in PD patients at risk for dementia. This finding may explain why the PIGD motor phenotype is a risk factor for the development of PDD.

KW - β-amyloid

KW - Dopamine

KW - MDS-UPDRS

KW - Parkinson's disease

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=84875483820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875483820&partnerID=8YFLogxK

U2 - 10.1002/mds.25213

DO - 10.1002/mds.25213

M3 - Article

C2 - 23239424

AN - SCOPUS:84875483820

VL - 28

SP - 296

EP - 301

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 3

ER -